Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Shares Outstanding (2019 - 2025)

Silo Pharma's Shares Outstanding history spans 7 years, with the latest figure at $10.5 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 133.08% year-over-year to $10.5 million; the TTM value through Sep 2025 reached $10.5 million, up 133.08%, while the annual FY2024 figure was $4.5 million, 41.95% up from the prior year.
  • Shares Outstanding for Q3 2025 was $10.5 million at Silo Pharma, up from $8.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $100.5 million in Q3 2022 and bottomed at $227.0 in Q2 2021.
  • The 5-year median for Shares Outstanding is $3.2 million (2022), against an average of $17.6 million.
  • The largest annual shift saw Shares Outstanding crashed 97.63% in 2021 before it soared 2324392.61% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $2.0 million in 2021, then soared by 60.14% to $3.2 million in 2022, then changed by 0.0% to $3.2 million in 2023, then skyrocketed by 41.95% to $4.5 million in 2024, then skyrocketed by 133.28% to $10.5 million in 2025.
  • Per Business Quant, the three most recent readings for SILO's Shares Outstanding are $10.5 million (Q3 2025), $8.7 million (Q2 2025), and $4.5 million (Q1 2025).